top of page
The Professional Network for Healthcare Experts
FDA authorises Aletta as first standalone robotic blood draw device for outpatient use
The authorisation introduces the first autonomous robotic system designed to perform blood collection under phlebotomist supervision, supporting outpatient services facing workforce pressures.
nuaxia
5 days ago2 min read
FDA approves OncoSil targeted radiation device for unresectable distal cholangiocarcinoma
The Humanitarian Device Exemption provides adults with unresectable, non-metastatic distal bile duct cancer with a new localised radiation option used alongside systemic therapy, although initial US use will be restricted to five centres participating in a post-approval study.
nuaxia
Aug 172 min read
bottom of page